|
|
Article: Geron to Present at 4 Upcoming Investor Conferences
- Article from:
- Wireless News
- Article date:
- September 6, 2009
CopyrightProvided by ProQuest LLC. (Hide copyright information)
|
Wireless News
09-06-2009
Geron to Present at 4 Upcoming Investor Conferences
Type: News
Geron Corp. announced that the company will present updates of its product development programs at four investor conferences in the month of September.
In a release, the Company noted event details:
Stephen M. Kelsey, M.D., F.R.C.P., F.R.C.Path., executive vice president and chief medical officer for oncology, will review Geron's portfolio of anti-cancer therapies, including its telomerase inhibitor drug (imetelstat - GRN163L) and its telomerase therapeutic vaccine (GRNVAC1) at the following conference:
- Rodman & Renshaw 11th Annual Healthcare Conference in New York, at 9:35 am ET on Thursday, ...